Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
( 26 27 26 27 I-clinical_variable
ANC 27 30 27 30 I-clinical_variable
) 30 31 30 31 I-clinical_variable
≥ 32 33 32 33 O
500 34 37 34 37 B-lower_bound
cells 38 43 38 43 I-lower_bound
/ 43 44 43 44 I-lower_bound
mm^3 44 48 44 48 I-lower_bound

Acute 0 5 49 54 B-chronic_disease
bacterial 6 15 55 64 I-chronic_disease
or 16 18 65 67 O
fungal 19 25 68 74 B-chronic_disease
infection 26 35 75 84 I-chronic_disease
requiring 36 45 85 94 O
intravenous 46 57 95 106 O
antibiotics 58 69 107 118 B-treatment
at 70 72 119 121 O
the 73 76 122 125 O
time 77 81 126 130 O
of 82 84 131 133 O
registration 85 97 134 146 O

Brachial 0 8 147 155 O
plexus 9 15 156 162 O
previously 16 26 163 173 O
irradiated 27 37 174 184 O
to 38 40 185 187 O
> 41 42 188 189 O
50 43 45 190 192 B-lower_bound
Gy 46 48 193 195 I-lower_bound

Brainstem 0 9 196 205 B-clinical_variable
previously 10 20 206 216 O
irradiated 21 31 217 227 O
to 32 34 228 230 O
> 35 36 231 232 O
50 37 39 233 235 B-lower_bound
Gy 40 42 236 238 I-lower_bound

Clinical 0 8 239 247 O
or 9 11 248 250 O
radiologic 12 22 251 261 O
evidence 23 31 262 270 O
of 32 34 271 273 O
untreated 35 44 274 283 O
and/or 45 51 284 290 O
progressive 52 63 291 302 B-cancer
brain 64 69 303 308 I-cancer
metastases 70 80 309 319 I-cancer

Creatinine 0 10 320 330 B-clinical_variable
clearance 11 20 331 340 I-clinical_variable
≥ 21 22 341 342 O
45 23 25 343 345 B-lower_bound
mL 26 28 346 348 I-lower_bound
/ 28 29 348 349 I-lower_bound
min/1.73 29 37 349 357 I-lower_bound
m^2 38 41 358 361 I-lower_bound
for 42 45 362 365 O
patients 46 54 366 374 O
with 55 59 375 379 O
creatinine 60 70 380 390 B-clinical_variable
levels 71 77 391 397 I-clinical_variable
above 78 83 398 403 O
institutional 84 97 404 417 O
normal 98 104 418 424 O

Cutaneous 0 9 425 434 B-cancer
metastasis 10 20 435 445 I-cancer
of 21 23 446 448 O
NSCLC 24 29 449 454 O

Imaging 0 7 455 462 O
proof 8 13 463 468 O
of 14 16 469 471 O
limited 17 24 472 479 O
metastatic 25 35 480 490 B-cancer
disease 36 43 491 498 O
and 44 47 499 502 O
response 48 56 503 511 O
to 57 59 512 514 O
therapy 60 67 515 522 O
/ 67 68 522 523 O
stable 68 74 523 529 B-cancer
disease 75 82 530 537 I-cancer
, 82 83 537 538 O
by 84 86 539 541 O
at 87 89 542 544 O
least 90 95 545 550 O
CT 96 98 551 553 B-treatment
chest 99 104 554 559 I-treatment
through 105 112 560 567 O
the 113 116 568 571 O
adrenals 117 125 572 580 O
or 126 128 581 583 O
PET 129 132 584 587 B-treatment
/ 132 133 587 588 I-treatment
CT 133 135 588 590 I-treatment
within 136 142 591 597 O
30 143 145 598 600 B-upper_bound
days 146 150 601 605 I-upper_bound
prior 151 156 606 611 I-upper_bound
to 157 159 612 614 O
registration 160 172 615 627 O

Known 0 5 628 633 O
human 6 11 634 639 B-chronic_disease
immunodeficiency 12 28 640 656 I-chronic_disease
virus 29 34 657 662 I-chronic_disease
( 35 36 663 664 I-chronic_disease
HIV 36 39 664 667 I-chronic_disease
) 39 40 667 668 I-chronic_disease
positive 41 49 669 677 O
with 50 54 678 682 O
cluster 55 62 683 690 O
of 63 65 691 693 O
differentiation 66 81 694 709 O
4 82 83 710 711 O
( 84 85 712 713 B-clinical_variable
CD4 85 88 713 716 I-clinical_variable
) 88 89 716 717 I-clinical_variable
count 90 95 718 723 I-clinical_variable
< 96 97 724 725 O
200 98 101 726 729 B-upper_bound
cells 102 107 730 735 I-upper_bound
/ 107 108 735 736 I-upper_bound
microliter 108 118 736 746 I-upper_bound

Lung 0 4 747 751 O
previously 5 15 752 762 O
irradiated 16 26 763 773 O
with 27 31 774 778 O
prior 32 37 779 784 O
V20 38 41 785 788 B-clinical_variable
Gy 42 44 789 791 I-clinical_variable
> 45 46 792 793 O
35 47 49 794 796 B-lower_bound
% 49 50 796 797 I-lower_bound

Participation 0 13 798 811 O
in 14 16 812 814 O
any 17 20 815 818 O
investigational 21 36 819 834 O
drug 37 41 835 839 O
study 42 47 840 845 O
( 48 49 846 847 O
excluding 49 58 847 856 O
non 59 62 857 860 O
- 62 63 860 861 O
oncology 63 71 861 869 O
and/or 72 78 870 876 O
symptom 79 86 877 884 O
management 87 97 885 895 O
studies 98 105 896 903 O
) 105 106 903 904 O
within 107 113 905 911 O
4 114 115 912 913 B-upper_bound
weeks 116 121 914 919 I-upper_bound
prior 122 127 920 925 I-upper_bound
to 128 130 926 928 O
registration 131 143 929 941 O

Patients 0 8 942 950 O
must 9 13 951 955 O
be 14 16 956 958 O
registered 17 27 959 969 O
within 28 34 970 976 O
35 35 37 977 979 B-upper_bound
days 38 42 980 984 I-upper_bound
of 43 45 985 987 O
administration 46 60 988 1002 O
of 61 63 1003 1005 O
the 64 67 1006 1009 O
last 68 72 1010 1014 O
dose 73 77 1015 1019 O
of 78 80 1020 1022 O
first 81 86 1023 1028 O
- 86 87 1028 1029 O
line 87 91 1029 1033 O
/ 91 92 1033 1034 O
induction 92 101 1034 1043 O
systemic 102 110 1044 1052 B-treatment
therapy 111 118 1053 1060 I-treatment

Patients 0 8 1061 1069 O
must 9 13 1070 1074 O
have 14 18 1075 1079 O
received 19 27 1080 1088 O
first 28 33 1089 1094 B-treatment
- 33 34 1094 1095 I-treatment
line 34 38 1095 1099 I-treatment
/ 38 39 1099 1100 I-treatment
induction 39 48 1100 1109 I-treatment
chemotherapy 49 61 1110 1122 I-treatment
( 62 63 1123 1124 O
4 63 64 1124 1125 O
cycles 65 71 1126 1132 O
) 71 72 1132 1133 O
and 73 76 1134 1137 O
achieved 77 85 1138 1146 O
stable 86 92 1147 1153 O
disease 93 100 1154 1161 O
or 101 103 1162 1164 O
a 104 105 1165 1166 O
partial 106 113 1167 1174 O
response 114 122 1175 1183 O

Patients 0 8 1184 1192 O
receiving 9 18 1193 1202 O
targeted 19 27 1203 1211 B-treatment
therapy 28 35 1212 1219 I-treatment
( 36 37 1220 1221 O
non 37 40 1221 1224 B-treatment
- 40 41 1224 1225 I-treatment
cytotoxic 41 50 1225 1234 I-treatment
systemic 51 59 1235 1243 I-treatment
therapy 60 67 1244 1251 I-treatment
) 67 68 1251 1252 O
for 69 72 1253 1256 O
NSCLC 73 78 1257 1262 B-cancer
in 79 81 1263 1265 O
the 82 85 1266 1269 O
first 86 91 1270 1275 O
- 91 92 1275 1276 O
line 92 96 1276 1280 O
setting 97 104 1281 1288 O

Patients 0 8 1289 1297 O
who 9 12 1298 1301 O
received 13 21 1302 1310 O
prior 22 27 1311 1316 O
non 28 31 1317 1320 O
- 31 32 1320 1321 O
induction 32 41 1321 1330 O
pembrolizumab 42 55 1331 1344 B-treatment
, 55 56 1344 1345 O
patients 57 65 1346 1354 O
on 66 68 1355 1357 O
chronic 69 76 1358 1365 O
steroids 77 85 1366 1374 B-treatment
or 86 88 1375 1377 O
who 89 92 1378 1381 O
have 93 97 1382 1386 O
active 98 104 1387 1393 O
autoimmune 105 115 1394 1404 B-chronic_disease
disease 116 123 1405 1412 I-chronic_disease
for 124 127 1413 1416 O
which 128 133 1417 1422 O
they 134 138 1423 1427 O
received 139 147 1428 1436 O
systemic 148 156 1437 1445 B-treatment
treatment 157 166 1446 1455 I-treatment
in 167 169 1456 1458 O
the 170 173 1459 1462 O
previous 174 182 1463 1471 B-upper_bound
2 183 184 1472 1473 I-upper_bound
years 185 190 1474 1479 I-upper_bound
with 191 195 1480 1484 O
corticosteroids 196 211 1485 1500 B-treatment
, 211 212 1500 1501 O
disease 213 220 1502 1509 B-treatment
modifying 221 230 1510 1519 I-treatment
agents 231 237 1520 1526 I-treatment
, 237 238 1526 1527 O
or 239 241 1528 1530 O
immunosuppressive 242 259 1531 1548 B-treatment
drugs 260 265 1549 1554 I-treatment

Patients 0 8 1555 1563 O
with 9 13 1564 1568 O
brain 14 19 1569 1574 B-cancer
metastases 20 30 1575 1585 I-cancer
are 31 34 1586 1589 O
eligible 35 43 1590 1598 O
if 44 46 1599 1601 O
these 47 52 1602 1607 O
lesions 53 60 1608 1615 O
have 61 65 1616 1620 O
been 66 70 1621 1625 O
previously 71 81 1626 1636 O
treated 82 89 1637 1644 O
and 90 93 1645 1648 O
the 94 97 1649 1652 O
patients 98 106 1653 1661 O
have 107 111 1662 1666 O
no 112 114 1667 1669 O
clinical 115 123 1670 1678 O
or 124 126 1679 1681 O
radiographic 127 139 1682 1694 O
evidence 140 148 1695 1703 O
of 149 151 1704 1706 O
progression 152 163 1707 1718 O
prior 164 169 1719 1724 O
to 170 172 1725 1727 O
enrollment 173 183 1728 1738 O

Patients 0 8 1739 1747 O
with 9 13 1748 1752 O
malignant 14 23 1753 1762 B-cancer
pleural 24 31 1763 1770 I-cancer
effusions 32 41 1771 1780 I-cancer
that 42 46 1781 1785 O
do 47 49 1786 1788 O
not 50 53 1789 1792 O
resolve 54 61 1793 1800 O
after 62 67 1801 1806 O
first 68 73 1807 1812 B-treatment
- 73 74 1812 1813 I-treatment
line 74 78 1813 1817 I-treatment
systemic 79 87 1818 1826 I-treatment
therapy 88 95 1827 1834 I-treatment

Patients 0 8 1835 1843 O
with 9 13 1844 1848 O
more 14 18 1849 1853 O
than 19 23 1854 1858 O
3 24 25 1859 1860 B-lower_bound
discrete 26 34 1861 1869 O
locations 35 44 1870 1879 O
of 45 47 1880 1882 O
extra 48 53 1883 1888 B-cancer
- 53 54 1888 1889 I-cancer
cranial 54 61 1889 1896 I-cancer
metastatic 62 72 1897 1907 I-cancer
disease 73 80 1908 1915 I-cancer
after 81 86 1916 1921 O
first 87 92 1922 1927 B-treatment
- 92 93 1927 1928 I-treatment
line 93 97 1928 1932 I-treatment
systemic 98 106 1933 1941 I-treatment
therapy 107 114 1942 1949 I-treatment
requiring 115 124 1950 1959 O
more 125 129 1960 1964 O
than 130 134 1965 1969 O
3 135 136 1970 1971 O
SBRT 137 141 1972 1976 O
plans 142 147 1977 1982 O
to 148 150 1983 1985 O
cover 151 156 1986 1991 O
these 157 162 1992 1997 O
distinct 163 171 1998 2006 O
metastatic 172 182 2007 2017 O
disease 183 190 2018 2025 O
entities 191 199 2026 2034 O

Platelets 0 9 2035 2044 B-clinical_variable
≥ 10 11 2045 2046 O
50,000 12 18 2047 2053 B-lower_bound
cells 19 24 2054 2059 I-lower_bound
/ 24 25 2059 2060 I-lower_bound
mm^3 25 29 2060 2064 I-lower_bound

Prior 0 5 2065 2070 O
bevacizumab 6 17 2071 2082 B-treatment
therapy 18 25 2083 2090 I-treatment

Prior 0 5 2091 2096 B-treatment
radiotherapy 6 18 2097 2109 I-treatment
for 19 22 2110 2113 O
patients 23 31 2114 2122 O
with 32 36 2123 2127 O
brain 37 42 2128 2133 B-cancer
metastases 43 53 2134 2144 I-cancer
prior 54 59 2145 2150 O
to 60 62 2151 2153 O
enrollment 63 73 2154 2164 O

Replacement 0 11 2165 2176 B-treatment
therapy 12 19 2177 2184 I-treatment
( 20 21 2185 2186 O
thyroxine 21 30 2186 2195 B-treatment
, 30 31 2195 2196 O
insulin 32 39 2197 2204 B-treatment
or 40 42 2205 2207 O
physiological 43 56 2208 2221 B-treatment
corticosteroid 57 71 2222 2236 I-treatment
replacement 72 83 2237 2248 I-treatment
for 84 87 2249 2252 O
adrenal 88 95 2253 2260 B-chronic_disease
or 96 98 2261 2263 I-chronic_disease
pituitary 99 108 2264 2273 I-chronic_disease
insufficiency 109 122 2274 2287 I-chronic_disease
) 122 123 2287 2288 O
is 124 126 2289 2291 O
allowed 127 134 2292 2299 O
. 134 135 2299 2300 O
Patients 136 144 2301 2309 O
with 145 149 2310 2314 O
active 150 156 2315 2321 O
interstitial 157 169 2322 2334 B-chronic_disease
lung 170 174 2335 2339 I-chronic_disease
disease 175 182 2340 2347 I-chronic_disease
or 183 185 2348 2350 O
who 186 189 2351 2354 O
have 190 194 2355 2359 O
a 195 196 2360 2361 O
history 197 204 2362 2369 O
of 205 207 2370 2372 O
pneumonitis 208 219 2373 2384 B-chronic_disease
for 220 223 2385 2388 O
which 224 229 2389 2394 O
they 230 234 2395 2399 O
had 235 238 2400 2403 O
received 239 247 2404 2412 O
glucocorticoids 248 263 2413 2428 B-treatment

Small 0 5 2429 2434 O
intestine 6 15 2435 2444 O
, 15 16 2444 2445 O
large 17 22 2446 2451 O
intestine 23 32 2452 2461 O
, 32 33 2461 2462 O
or 34 36 2463 2465 O
stomach 37 44 2466 2473 O
previously 45 55 2474 2484 O
irradiated 56 66 2485 2495 O
to 67 69 2496 2498 O
> 70 71 2499 2500 O
45 72 74 2501 2503 B-lower_bound
Gy 75 77 2504 2506 I-lower_bound

Spinal 0 6 2507 2513 B-clinical_variable
cord 7 11 2514 2518 I-clinical_variable
previously 12 22 2519 2529 I-clinical_variable
irradiated 23 33 2530 2540 I-clinical_variable
to 34 36 2541 2543 O
> 37 38 2544 2545 O
40 39 41 2546 2548 B-lower_bound
Gy 42 44 2549 2551 I-lower_bound

Total 0 5 2552 2557 O
bilirubin 6 15 2558 2567 B-clinical_variable
≤ 16 17 2568 2569 O
1.5 18 21 2570 2573 B-upper_bound
× 22 23 2574 2575 I-upper_bound
ULN 24 27 2576 2579 I-upper_bound

men 0 3 2580 2583 B-gender
who 4 7 2584 2587 O
are 8 11 2588 2591 O
sexually 12 20 2592 2600 O
active 21 27 2601 2607 O

patients 0 8 2608 2616 O
newly 9 14 2617 2622 O
diagnosed 15 24 2623 2632 O
with 25 29 2633 2637 O
metastatic 30 40 2638 2648 B-cancer
disease 41 48 2649 2656 I-cancer
or 49 51 2657 2659 O
those 52 57 2660 2665 O
initially 58 67 2666 2675 O
diagnosed 68 77 2676 2685 O
and 78 81 2686 2689 O
treated 82 89 2690 2697 O
for 90 93 2698 2701 O
stage 94 99 2702 2707 B-lower_bound
I 100 101 2708 2709 I-lower_bound
- 101 102 2709 2710 O
III 102 105 2710 2713 B-upper_bound
NSCLC 106 111 2714 2719 B-cancer
who 112 115 2720 2723 O
ultimately 116 126 2724 2734 O
develop 127 134 2735 2742 O
metastases 135 145 2743 2753 B-cancer

patients 0 8 2754 2762 O
with 9 13 2763 2767 O
pleural 14 21 2768 2775 B-chronic_disease
effusions 22 31 2776 2785 I-chronic_disease
that 32 36 2786 2790 O
have 37 41 2791 2795 O
become 42 48 2796 2802 O
too 49 52 2803 2806 O
small 53 58 2807 2812 O
for 59 62 2813 2816 O
thoracentesis 63 76 2817 2830 O
at 77 79 2831 2833 O
the 80 83 2834 2837 O
time 84 88 2838 2842 O
of 89 91 2843 2845 O
registration 92 104 2846 2858 O
would 105 110 2859 2864 O
be 111 113 2865 2867 O
permitted 114 123 2868 2877 O
on 124 126 2878 2880 O
study 127 132 2881 2886 O
, 132 133 2886 2887 O
indicating 134 144 2888 2898 O
a 145 146 2899 2900 O
significant 147 158 2901 2912 O
response 159 167 2913 2921 O
to 168 170 2922 2924 O
first 171 176 2925 2930 O
- 176 177 2930 2931 O
line 177 181 2931 2935 O
chemotherapy 182 194 2936 2948 B-treatment

pregnant 0 8 2949 2957 B-pregnancy

willing 0 7 2958 2965 B-contraception_consent
and 8 11 2966 2969 I-contraception_consent
able 12 16 2970 2974 I-contraception_consent
to 17 19 2975 2977 I-contraception_consent
use 20 23 2978 2981 I-contraception_consent
medically 24 33 2982 2991 I-contraception_consent
acceptable 34 44 2992 3002 I-contraception_consent
forms 45 50 3003 3008 I-contraception_consent
of 51 53 3009 3011 I-contraception_consent
contraception 54 67 3012 3025 I-contraception_consent
during 68 74 3026 3032 O
the 75 78 3033 3036 O
trial 79 84 3037 3042 O
and 85 88 3043 3046 O
for 89 92 3047 3050 O
up 93 95 3051 3053 O
to 96 98 3054 3056 O
180 99 102 3057 3060 B-upper_bound
days 103 107 3061 3065 I-upper_bound
after 108 113 3066 3071 O
completion 114 124 3072 3082 O
of 125 127 3083 3085 O
all 128 131 3086 3089 O
treatment 132 141 3090 3099 B-treatment
to 142 144 3100 3102 O
prevent 145 152 3103 3110 O
pregnancy 153 162 3111 3120 B-pregnancy
or 163 165 3121 3123 O
fathering 166 175 3124 3133 O
a 176 177 3134 3135 O
child 178 183 3136 3141 O

